These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33784225)

  • 1. Effect of formula factors on the properties of HPMC plant hollow capsule film.
    Ding H; He S; Luo W; Liu L; Wang S; Chen X
    Drug Dev Ind Pharm; 2021 Jul; 47(7):1052-1063. PubMed ID: 33784225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on formulation and preparation technology of the composite cellulose-based enteric capsule shells.
    Liu L; Luo H; Yang Y; Huang J; Liu C; Ding Q; Zhang H
    Drug Dev Ind Pharm; 2022 Nov; 48(11):646-656. PubMed ID: 36469628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
    Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K
    Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules.
    Cole ET; Scott RA; Cade D; Connor AL; Wilding IR
    Pharm Res; 2004 May; 21(5):793-8. PubMed ID: 15180336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance qualification of a new hypromellose capsule: Part II. Disintegration and dissolution comparison between two types of hypromellose capsules.
    Ku MS; Lu Q; Li W; Chen Y
    Int J Pharm; 2011 Sep; 416(1):16-24. PubMed ID: 21356291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of formulation conditions on hypromellose performance properties in films used for capsules and tablet coatings.
    Curtis-Fisk J; Sheskey P; Balwinski K; Coppens K; Mohler C; Zhao J
    AAPS PharmSciTech; 2012 Dec; 13(4):1170-8. PubMed ID: 22961412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid Based Formulations in Hard Gelatin and HPMC Capsules: a Physical Compatibility Study.
    Koehl NJ; Shah S; Tenekam ID; Khamiakova T; Sauwen N; Vingerhoets S; Coppenolle H; Holm R
    Pharm Res; 2021 Aug; 38(8):1439-1454. PubMed ID: 34378150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPMC capsules: current status and future prospects.
    Al-Tabakha MM
    J Pharm Pharm Sci; 2010; 13(3):428-42. PubMed ID: 21092714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hard gelatin and hypromellose (HPMC) capsules: estimation of rupture time by real-time dissolution spectroscopy.
    El-Malah Y; Nazzal S; Bottom CB
    Drug Dev Ind Pharm; 2007 Jan; 33(1):27-34. PubMed ID: 17192248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability and in vitro oesophageal sticking tendency of hydroxypropyl methylcellulose capsule formulations and corresponding gelatine capsule formulations.
    Honkanen O; Laaksonen P; Marvola J; Eerikäinen S; Tuominen R; Marvola M
    Eur J Pharm Sci; 2002 Jun; 15(5):479-88. PubMed ID: 12036724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time domain 1H NMR as a new method to monitor softening of gelatin and HPMC capsule shells.
    Kuentz M; Rothenhäusler B; Röthlisberger D
    Drug Dev Ind Pharm; 2006; 32(10):1165-73. PubMed ID: 17090439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A formulation approach for development of HPMC-based sustained release tablets for tolterodine tartrate with a low release variation.
    Cao QR; Choi JS; Liu Y; Xu WJ; Yang M; Lee BJ; Cui JH
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1720-30. PubMed ID: 23062115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Hydroxypropyl Methylcellulose on Physicochemical Properties and Microstructure of κ-Carrageenan Film.
    Guo J; Dong S; Ye M; Wu X; Lv X; Xu H; Li M
    Foods; 2022 Sep; 11(19):. PubMed ID: 36230097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A scintigraphic investigation of the disintegration behaviour of capsules in fasting subjects: a comparison of hypromellose capsules containing carrageenan as a gelling agent and standard gelatin capsules.
    Tuleu C; Khela MK; Evans DF; Jones BE; Nagata S; Basit AW
    Eur J Pharm Sci; 2007 Mar; 30(3-4):251-5. PubMed ID: 17188473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Physico-mechanical Properties and Electrostatic Charging Behavior of Different Capsule Types for Inhalation Under Distinct Environmental Conditions.
    Pinto JT; Wutscher T; Stankovic-Brandl M; Zellnitz S; Biserni S; Mercandelli A; Kobler M; Buttini F; Andrade L; Daza V; Ecenarro S; Canalejas L; Paudel A
    AAPS PharmSciTech; 2020 May; 21(4):128. PubMed ID: 32399597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model.
    Vardakou M; Mercuri A; Naylor TA; Rizzo D; Butler JM; Connolly PC; Wickham MS; Faulks RM
    Int J Pharm; 2011 Oct; 419(1-2):192-9. PubMed ID: 21843611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
    Wu Y; Zhao F; Paborji M
    Pharm Dev Technol; 2003; 8(4):379-83. PubMed ID: 14601962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disintegration behaviour of capsules in fed subjects: a comparison of hypromellose (carrageenan) capsules and standard gelatin capsules.
    Jones BE; Basit AW; Tuleu C
    Int J Pharm; 2012 Mar; 424(1-2):40-3. PubMed ID: 22214655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of solvents on physical properties and release characteristics of monolithic hydroxypropylmethylcellulose matrix granules and tablets.
    Cao QR; Choi YW; Cui JH; Lee BJ
    Arch Pharm Res; 2005 Apr; 28(4):493-501. PubMed ID: 15918526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of food on a gastrically degraded drug: azithromycin fast-dissolving gelatin capsules and HPMC capsules.
    Curatolo W; Liu P; Johnson BA; Hausberger A; Quan E; Vendola T; Vatsaraj N; Foulds G; Vincent J; Chandra R
    Pharm Res; 2011 Jul; 28(7):1531-9. PubMed ID: 21331473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.